pentylenetetrazole has been researched along with myelin basic protein in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, H; Chen, LW; Gao, GD; Liu, B; Wang, C; You, Y; Zhang, H | 1 |
| Bai, H; Liu, Z; Meng, F; Xu, R; You, Y; Zhang, H; Zhao, Y | 1 |
2 other study(ies) available for pentylenetetrazole and myelin basic protein
| Article | Year |
|---|---|
Myelin damage of hippocampus and cerebral cortex in rat pentylenetetrazol model.
Topics: Animals; Autoantibodies; Blood-Brain Barrier; Blotting, Western; Cerebral Cortex; Electroencephalography; Enzyme-Linked Immunosorbent Assay; Epilepsy; Hippocampus; Immunohistochemistry; Male; Myelin Basic Protein; Myelin Sheath; Nerve Fibers, Myelinated; Oligodendroglia; Pentylenetetrazole; Rats; Rats, Sprague-Dawley | 2011 |
Glatiramer acetate, an anti-demyelination drug, reduced rats' epileptic seizures induced by pentylenetetrazol via protection of myelin sheath.
Topics: Animals; Anticonvulsants; Cerebral Cortex; Epilepsy; Glatiramer Acetate; Hippocampus; Male; Myelin Basic Protein; Myelin Sheath; Pentylenetetrazole; Peptides; Rats; Rats, Sprague-Dawley | 2013 |